Dakė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 53,665 | 59,013 | 74,775 | 78,678 | 79,434 | 89,348 | 87,494 | 95,422 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -674 | 3,014 | 277 | 316 | 1,054 | 600 | 5,105 | 3,054 |
| Equity | -8,095 | -5,081 | -4,804 | -4,488 | -3,434 | -2,834 | 2,271 | 5,325 |
| Liabilities | 0 | 0 | 9,215 | 9,120 | 11,787 | 9,218 | 7,436 | 6,856 |
| Non-current assets | 276 | 276 | 276 | 276 | 276 | 276 | 276 | 478 |
| Current assets | 3,203 | 5,193 | 4,002 | 4,157 | 7,327 | 5,866 | 9,191 | 11,623 |
| Total assets | 3,479 | 5,469 | 4,278 | 4,433 | 7,603 | 6,142 | 9,467 | 12,101 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 6,243 | 7,399 | 9,815 |
| Social insurance contributions | - | - | - | - | - | 4,739 | 4,060 | 6,146 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +15.8% | +10.0% | +26.7% | +5.2% | +1.0% | +12.5% | -2.1% | +9.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -19.4% | 55.1% | 6.5% | 7.1% | 13.9% | 9.8% | 53.9% | 25.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | 224.8% | 57.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.3% | 5.1% | 0.4% | 0.4% | 1.3% | 0.7% | 5.8% | 3.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | 3.3 | 1.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 13,416 | 14,753 | 18,694 | 19,670 | 18,331 | 21,443 | 20,998 | 22,452 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dakė - Social security debts
The company had no debts to Sodra
Dakė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-12 | 2026-08-13 | 36.37 |
| 2026-04-10 | 2026-04-13 | 197.41 |
| 2026-03-13 | 2026-03-16 | 225.63 |
| 2026-01-10 | 2026-01-15 | 204.84 |
| 2025-12-12 | 2025-12-15 | 215.62 |
| 2025-12-10 | 2025-12-11 | 215.02 |
| 2025-11-12 | 2025-11-15 | 248.61 |
| 2025-09-09 | 2025-09-14 | 634.79 |
| 2025-06-14 | 2025-06-16 | 43.63 |
| 2025-05-11 | 2025-05-13 | 185.95 |
| 2025-05-08 | 2025-05-10 | 185.85 |
| 2025-05-07 | 2025-05-07 | 185.5 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dake, UAB (code 304298013) is a Private Limited Liability Company engaged in retail sale of pharmaceutical products. In 2025, the company generated revenue of €95.4K, up 9.1% year on year and 6.8% over two years. Net profit was €3.1K, with a profit margin of 3.2%. The 2025 result followed revenue of €87.5K and net profit of €5.1K in 2024, compared with €89.3K and €600 in 2023, showing a stable revenue base and fluctuating profitability over the period. The balance sheet strengthened in 2025, with total assets rising to €12.1K, equity increasing to €5.3K, and liabilities standing at €6.9K. Short-term assets accounted for most of the asset base at €11.6K, while long-term assets were €478. Key efficiency indicators for 2025 were strong, including ROE of 57.4%, ROA of 25.2%, debt-to-equity of 1.29, and asset turnover of 7.89x. Revenue per employee was €23.9K and profit per employee €764.